[1] Ali B, Panossian A, Taghinia A, et al.Diffuse venous malformations of the upper extremity (Bockenheimer disease): diagnosis and management[J]. Plast Reconstr Surg, 2020, 146(6): 1317-1324. [2] Swerdlin RF, Briones MA, Gill AE, et al.Coagulopathy and related complications following sclerotherapy of congenital venous malformations[J]. Pediatr Blood Cancer, 2022, 69(5): e29610. [3] Hermans C, Dessomme B, Lambert C, et al.Venous malformations and coagulopathy[J]. Ann Chir Plast Esthet, 2006, 51(4-5): 388-393. [4] Mack JM, Crary SE.How we approach coagulopathy with vascular anomalies[J]. Pediatr Blood Cancer, 2022, 69(Suppl 3): e29353. [5] Budge EJ, Khalil Allam MA, Mechie I, et al.Venous malformations: coagulopathy control and treatment methods[J]. Phlebology, 2021,36(5): 361-374. [6] Lee SY, Kim KR.Factors affecting adverse events after venous malformation sclerotherapy[J]. J Vasc Interv Radiol, 2022, 33(12): 1548-1557. [7] Hung JW, Leung MW, Liu CS, et al.Venous malformation and localized intravascular coagulopathy in children[J]. Eur J Pediatr Surg, 2017, 27(2): 181-184. [8] Soblet J, Kangas J, Nätynki M, et al.Blue rubber bleb nevus (BRBN) syndrome is caused by somatic TEK (TIE2) mutations[J]. J Invest Dermatol, 2017,137(1): 207-216. [9] Limaye N, Wouters V, Uebelhoer M, et al.Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformations[J]. Nat Genet, 2009, 41(1): 118-124. [10] Nätynki M, Kangas J, Miinalainen I, et al.Common and specific effects of TIE2 mutations causing venous malformations[J]. Hum Mol Genet, 2015, 24(22): 6374-6389. [11] Dompmartin A, Acher A, Thibon P, et al.Association of localized intravascular coagulopathy with venous malformations[J]. Arch Dermatol, 2008, 144(7): 873-877. [12] 邰茂众, 周善良, 李克雷, 等. 静脉畸形患者围术期D二聚体、纤维蛋白原的动态变化及临床意义[J]. 中国口腔颌面外科杂志, 2014, 12(4): 351-355. Tai MZ, Zhou SL, Li KL, et al.Dynamic changes and clinical significance of D-dimer and fibrinogen in patients with malformations around perioperative period[J]. China Journal of Oral and Maxillofacial Surgery, 2014, 12(4): 351-355. [13] Mazoyer E, Enjolras O, Bisdorff A, et al.Coagulation disorders in patients with venous malformation of the limbs and trunk: a case series of 118 patients[J]. Arch Dermatol, 2008,144(7): 861-867. [14] Koo KS, Dowd CF, Mathes EF, et al.MRI phenotypes of localized intravascular coagulopathy in venous malformations[J]. Pediatr Radiol, 2015, 45(11): 1690-1695. [15] 王德明, 苏立新, 范新东,等. 静脉畸形中国专家共识[J]. 介入放射学杂志, 2019, 28(4): 307-311. Wang DM, Su LX, Fan XD, et al.Consensus of Chinese experts on venous malformations[J].Journal of Interventional Radiology, 2019, 28(4): 307-311. [16] 郑家伟, 赵怡芳, 秦中平, 等. 口腔颌面-头颈部静脉畸形诊治指南[J]. 中国口腔颌面外科杂志, 2011, 9(6): 510-517. Zheng JW, Zhao YF, Qin ZP, et al.Treatment guideline of oro-maxillofacial head and neck venous malformations[J]. China Journal of Oral and Maxillofacial Surgery, 2011, 9(6): 510-517. [17] 葛春晓, 邰茂众, 陈涛, 等. 累及咽峡区的颌面颈部静脉畸形143例治疗分析[J]. 中华耳鼻咽喉头颈外科杂志, 2017,52(12): 909-914. Ge CX, Tai MZ, Chen T, et al.Treatment analyses of 143 patients with maxillofacial and cervical venous malformations involved in isthmus faucium area[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery,2017,52(12): 909-914. [18] Aronniemi J, Långström S, Mattila KA, et al.Venous malformations and blood coagulation in children[J]. Children (Basel), 2021, 8(4): 312-322. [19] Xu Z, Yang Y, Ge C, et al.Venous malformations of the lower limb with severe localized intravascular coagulopathy treated with radiofrequency ablation and resection[J]. J Thromb Thrombolysis, 2023, 56(1): 202-206. [20] Herman R, Kunisaki S, Molitor M, et al.Rectal bleeding, deep venous thrombosis, and coagulopathy in a patient with Klippel-Trénaunay syndrome[J]. J Pediatr Surg, 2012, 47(3): 598-600. [21] Chun HJ, Osuga K, Ukai I, et al.Spontaneous splenic rupture due to extensive venous malformation with consumptive coagulopathy: treatment with splenic artery embolization[J]. Jpn J Radiol, 2010, 28(5): 381-384. [22] Tai MZ, Wang YP, Chen T, et al.Venous malformations with severe localized intravascular coagulopathy treated with microwave ablation[J]. Vascular, 2022, 30(4): 779-786. [23] Zhuo K, Russell S, Wargon O, et al.Disseminated intravascular coagulopathy in a child with extensive venous malformations[J]. J Paediatr Child Health, 2017, 53(3): 320-321. [24] Shastry S, Mohan G, Pa P, et al.Role of Thromboelastogram in monitoring the activation of the coagulation pathway and assessing the associated risk factors for hypercoagulable state in transfusion dependent thalassemia patients[J]. Transfus Apher Sci, 2023, 62(2): 103583. [25] Khanna P, Sinha C, Singh AK, et al.The role of point of care thromboelastography (TEG) and thromboelastometry (ROTEM) in management of primary postpartum haemorrhage: a meta-analysis and systematic review[J]. Saudi J Anaesth, 2023,17(1): 23-32. [26] Sharma S, Chauhan A.Prophylactic blood product transfusions in post-endoscopic band ligation bleeding-'tag in TEG'[J]. JHEP Rep, 2021,4(1): 100395. [27] Eikelboom R, Manji RA.Commentary: reducing unnecessary transfusions in cardiac surgery: a TEG talk[J]. J Thorac Cardiovasc Surg, 2024, 167(1): 254-255. [28] Phillips R, Moore H, Bensard D, et al.It is time for TEG in pediatric trauma: unveiling meaningful alterations in children who undergo massive transfusion[J]. Pediatr Surg Int, 2021, 37(11): 1613-1620. [29] Lee BB, Kim DI, Huh S, et al.New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation[J]. J Vasc Surg, 2001, 33(4): 764-772. [30] Bhattacharjee K, Rehman O, Venkatraman V, et al.Blood within the bone: orbital intraosseous venous malformation[J]. Orbit, 2024,23: 1-13. [31] 李爱萍, 邰茂众, 秦中平. 面颈深部静脉畸形和淋巴管畸形的彩色多普勒超声鉴别诊断[J]. 中国口腔颌面外科杂志, 2015, 13(1): 54-57. Li AP, Tai MZ, Qin ZP.Diagnosis of deep facial and cervical lymphatic malformation and venous malformation with color Doppler ultrasonography[J]. China Journal of Oral and Maxillofacial Surgery, 2015,13(1): 54-57. [32] Razek AA, Ashmalla GA.Prediction of venous malformations with localized intravascular coagulopathy with diffusion-weighted magnetic resonance imaging[J]. Phlebology, 2019,34(3): 156-161. [33] Hiruma H, Kitsukawa K, Ogawa Y, et al.Venous malformation of the foot: spontaneous regression postpartum on MRI[J]. Radiol Case Rep, 2020,16(1): 62-65. [34] Antúnez-Conde R, Navarro Cuéllar C, Salmerón Escobar JI, et al.Intraosseous venous malformation of the zygomatic bone: comparison between virtual surgical planning and standard surgery with review of the literature[J]. J Clin Med, 2021, 10(19): 4565. [35] Puig S, Aref H, Chigot V, et al.Classification of venous malformations in children and implications for sclerotherapy[J]. Pediatr Radiol, 2003,33(2): 99-103. [36] Mazoyer E, Enjolras O, Laurian C, et al.Coagulation abnormalities associated with extensive venous malformations of the limbs: differentiation from Kasabach-Merritt syndrome[J]. Clin Lab Haematol, 2002, 24(4): 243-251. [37] 中华医学会整形外科分会血管瘤和脉管畸形学组. 血管瘤和脉管畸形的诊断及治疗指南(2019版)[J]. 组织工程与重建外科杂志, 2019, 15(5): 277-317. Hemangioma and Vascular teratology Group, Plastic Surgery Branch, Chinese Medical Association. CSSVA guidelines for vascular anomalies 2019[J]. Journal of Tissue Engineering and Reconstructive Surgery, 2019, 15(5): 277-317. [38] Liu H, Hu L, Yang X, et al. Dabigatran etexilate is efficacious in consumptive coagulopathy and pain associated with venous malformations[J]. J Vasc Surg Venous Lymphat Disord, 2023,11(2):397-403.e1. [39] Fresa M, Mazzolai L.Venous malformation of the penis treated with a combined Nd:YAG laser and sclerotherapy technique[J]. Skin Health Dis, 2022, 2(3): e114. [40] Gocal W, Hilal E, Tragon T.Nd:YAG laser treatment of massive tongue venous malformation: a case report[J]. Ear Nose Throat J, 2022: 1455613221086030. [41] Fresa M, Ney B, Qanadli SD, et al.Advances in the treatment of complex venous malformation: endovenous laser[J]. Rev Med Suisse, 2020,16(718): 2387-2390. [42] Lee BB, Baumgartner I, Berlien HP, et al.Consensus document of the International Union of Angiology(IUA)-2013. Current concept on the management of arterio-venous management[J]. Int Angiol,2013,32(1):9-36. [43] 国际血管联盟中国分部血管畸形专家委员会. 动静脉畸形诊断与介入治疗专家共识[J]. 中国血管外科杂志(电子版), 2020, 12(3): 180-184. Expert Committee on Vascular Malformations, China Branch of the International Vascular Union. Expert consensus on diagnosis and interventional therapy of arteriovenous malformation[J]. Chinese Journal of Vascular Surgery(Electronic Version), 2020, 12(3): 180-184. [44] 郭磊, 宋丹, 王亮. 泡沫硬化剂治疗静脉畸形中国专家共识[J]. 血管与腔内血管外科杂志,2022, 8(11): 1281-1285,1310. Guo L, Song D, Wang L.Consensus of Chinese experts on the treatment of venous malformation with foam sclerosant[J]. Journal of Vascular and Endovascular Surgery, 2022, 8(11): 1281-1285, 1310. [45] 中华口腔医学会口腔颌面外科专业委员会脉管性疾病学组. 平阳霉素治疗脉管性疾病规范[J]. 中国口腔颌面外科杂志, 2011, 9(1): 68-69. Vascular Diseases Group, Oral and maxillofacial Surgery Committee, Chinese Stomatological Association. Guideline of using pingyangmycin to treat hemangioma and vascular malformations[J]. China Journal of Oral and Maxillofacial Surgery, 2011, 9(1): 68-69. [46] Li K, Tai M, Qin Z, et al.Clinical observations in mesh suture treatment for infants of Kasabach-Merritt phenomenon[J]. J Paediatr Child Health, 2015, 51(5): 529-533. [47] Duteau V, Espitia O, Perret C, et al.Cryoablation of soft tissues low-flow vascular malformations: clinical outcomes and safety[J]. Cardiovasc Intervent Radiol, 2022, 45(12): 1784-1792. [48] 吴颖, 范卫君. 肿瘤消融治疗的发展历史、现状及展望[J]. 中国研究型医院, 2021, 8(1): 22-26. Wu Y, Fan WJ.The past, present and future of tumor ablation therapy[J]. Chinese Research Hospitals, 2021, 8(1): 22-26. [49] 邰茂众, 葛春晓, 李克雷, 等. 彩色超声全时监测下经皮低功率动态射频消融治疗复杂静脉畸形的临床效果[J]. 中华医学美学美容杂志, 2018, 24(1): 42-45. Tai MZ, Ge CX, Li KL, et al.Clinical efficacy of complex venous malformations treated by percutaneous radiofrequency dynamic abla- tion with low power under real-time color Doppler monitoring[J]. Chinese Journal of Medical Aesthetics and Cosmetology, 2018, 24(1): 42-45. [50] 乔军波, 李金, 马玉春, 等. 成人全身多发重症静脉血管畸形综合征的治疗探讨[J]. 中华医学杂志, 2015, 95(18): 1430-1431. Qiao JB, Li J, Ma YC, et al.Treatment of multiple severe systemic venous malformation syndrome in adults[J]. National Medical Journal of China, 2015, 95(18): 1430-1431. [51] Boscolo E, Limaye N, Huang L, et al.Rapamycin improves TIE2-mutated venous malformation in murine model and human subjects[J]. J Clin Invest, 2015,125(9): 3491-3504. [52] Abdelbaky MA, Ragab IA, Abouzeid AA, et al.Sirolimus: a rescue drug to control complications of extensive venous malformation[J]. European J Pediatr Surg Rep, 2020, 8(1): e90-e94. [53] Ji Y, Chen S, Yang K, et al. A prospective multicenter study of sirolimus for complicated vascular anomalies[J]. J Vasc Surg, 2021,74(5): 1673-1681.e1673. [54] Adams DM, Trenor CC, 3rd, Hammill AM, et al. Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies[J]. Pediatrics, 2016,137(2): e20153257. [55] Maruani A, Tavernier E, Boccara O, et al.Sirolimus (rapamycin) for slow-flow malformations in children: the observational-phase randomized clinical PERFORMUS Trial[J]. JAMA Dermatol, 2021, 157(11): 1289-1298. [56] Novelli PM, Tublin JM, Orons PD.Correcting coagulopathy for image-guided procedures[J]. Semin Intervent Radiol, 2022, 39(4): 428-434. [57] Karcioglu O, Yilmaz S, Afacan G, et al.An update of the efficacy and comparative characteristics of direct (new) oral anticoagulants (DOACs)[J]. Cardiovasc Hematol Agents Med Chem, 2022, 20(2): 114-124. |